secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001703057-23-000014
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera shareholders elect directors, ratify auditor, approve say-on-pay at 2023 annual meeting
--------------------------------------------------------------------------------

- John S. Montalbano elected with 167.3M for, 11.0M against; Peter Thiel with 131.2M for, 47.0M against.
- Ratification of KPMG as auditor approved: 201.0M for, 0.3M against, 0.2M abstain.
- Non-binding say-on-pay compensation approved: 159.4M for, 18.6M against, 0.4M abstain.
- Total shares outstanding at record date: 288.7M; broker non-votes on director and say-on-pay: 23.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000170305723000014/0001703057-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000170305723000014/abcl-20230615.htm
  HTML page:      https://secwatch.observer/filing/0001703057-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer